Overview Fundamentals API Earnings EOD API Sample Code Pricing

CAPRICOR THERAP. DL-001 (4LN2 F) stock market data APIs

€19.22 0.1(0.5%) as of October 29, 2024
Price chart is built with Anychart

Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment of duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs. The company's lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase 3 clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD). It also focused on developing StealthX, an engineered exosome-based vaccine candidate, under phase 1 clinical study for a range of therapeutic applications, including targeted RNA, protein, and small molecule therapeutics to treat or prevent a variety of diseases. In addition, the company develops CAP-2003, under pre-clinical development for the treatment of trauma related injuries and conditions. It has collaboration and distribution agreement with Nippon Shinyaku Co. Ltd., collaboration agreement with National Institute of Allergy and Infectious Diseases, license agreements with the Johns Hopkins University and Cedars-Sinai Medical Center, as well as cell line license agreement with Life Technologies Corporation. The company was founded in 2005 and is headquartered in San Diego, California.

CAPRICOR THERAP. DL-001 Financial Data Overview

19.12
19.22
-
19.22
18.76
2.54-20.45
920 M
45 406 K
27 152 K
-0.21
4.029
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: '4LN2',
Type: 'Common Stock',
Name: 'CAPRICOR THERAP. DL-001',
Exchange: 'F',
CurrencyCode: 'EUR',
CurrencyName: 'Euro',
CurrencySymbol: '€',
CountryName: 'Germany',
CountryISO: 'DE',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Biotechnology',
CUSIP: NULL,
}

CAPRICOR THERAP. DL-001 Fundamental Data is available in our Financial Data APIs

  • Net Revenue 27 152 K
  • EBITDA -28 730 592
  • Earnings Per Share -0.82
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get CAPRICOR THERAP. DL-001 Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast -0.23

Get CAPRICOR THERAP. DL-001 End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com